Search results
Found 354 matches for
Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis
Clinical Neurology Research Teaching
21 September 2022
Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.
Repurposed drug could help patients with motor neuron disease
Clinical Neurology Research
11 August 2022
A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.
Finding out more about Parkinson’s by monitoring symptoms at home
Clinical Neurology Research
8 August 2022
Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.
Insights into the molecular pathways of progressive multiple sclerosis
Clinical Neurology Research
24 June 2022
Text by Ian Fyfe for 'Nature Reviews Neurology'
Discovery of gene involved in chronic pain creates new treatment target
Clinical Neurology Research
15 June 2022
Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.
Lymph nodes reveal more about mechanisms of autoimmunity
Clinical Neurology Research
13 June 2022
Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.
Multiple heart-related conditions linked to triple dementia risk, regardless of genetics
Clinical Neurology Research
9 June 2022
Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.
NDCN research presented at Myasthenia Gravis conference
Clinical Neurology Research
7 June 2022
The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.
European Magnetic Resonance Imaging in MS Group celebrates 20 years
Clinical Neurology Event
20 May 2022
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
Clinical Neurology Research
16 May 2022
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.
Funding awarded for autoimmune disease research
Clinical Neurology Research
13 May 2022
Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
Oxford researchers part of major UK initiative to understand chronic pain
Clinical Neurology Integrative Neuroimaging Research
10 May 2022
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Little understood brain region linked to how we perceive pain
Clinical Neurology Integrative Neuroimaging Research
28 March 2022
A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
New funding awarded to study persistent pain in inflammatory arthritis
Clinical Neurology Research
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
First-in-human implant of a “closed-loop” bioelectronic research system for investigating treatments for brain disorders
Clinical Neurology
7 February 2022
Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in Parkinson’s-like Multiple Systems Atrophy (MSA).
Attention and memory deficits persist for months after recovery from mild COVID
Clinical Neurology Coronavirus Research
19 January 2022
Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.
New spinout company: Human-Centric Drug Discovery
Clinical Neurology Research
7 January 2022
Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
Funding received for research into Motor Neuron Disease
Clinical Neurology Research
5 January 2022
A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
Protein test could lead to earlier and better diagnosis of Parkinson’s
Clinical Neurology Research
13 December 2021
Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize
Clinical Neurology Coronavirus Research
19 November 2021
In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.